NHS England says it cannot fund all cost-effective treatments promptly
Can the NHS still afford to fund all the treatments and technologies the National Institute for Health and Care Excellence (NICE) recommends? The answer, from NHS England, seems to be no – and it has now published, along with NICE, a set of ideas for how to handle that.
This is just one more example of the growing financial pressure on the NHS. It has big implications for how far the service will stay abreast of cutting edge, if sometimes only incremental, advances in medical technology in general, and pharmaceuticals in particular. This is a big issue.
It has come to a head because over the past year or two, as the money has got ever tighter, NHS England has held back on implementing a small number of recommendations from the National Institute of Health and Care Excellence – despite the theory that the service, certain circumstances excepted, should implement all the cost-effective treatments that NICE recommends within 90 days.
Can the NHS still afford to fund all the treatments and technologies the National Institute for Health and Care Excellence (NICE) recommends? The answer, from NHS England, seems to be no – and it has now published, along with NICE, a set of ideas for how to handle that.
This is just one more example of the growing financial pressure on the NHS. It has big implications for how far the service will stay abreast of cutting edge, if sometimes only incremental, advances in medical technology in general, and pharmaceuticals in particular. This is a big issue.
It has come to a head because over the past year or two, as the money has got ever tighter, NHS England has held back on implementing a small number of recommendations from the National Institute of Health and Care Excellence – despite the theory that the service, certain circumstances excepted, should implement all the cost-effective treatments that NICE recommends within 90 days.